Today: 6 April 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Home Depot stock price slips as tariff fears hit retailers, even after TD Cowen raises target

Home Depot stock price slips as tariff fears hit retailers, even after TD Cowen raises target

Home Depot shares fell 1.4% to $374.87 Tuesday after President Trump announced new tariffs on European imports, sparking a broader selloff in consumer stocks. Lowe’s dropped 3.4%, and the SPDR S&P Homebuilders ETF lost 2.2%. Home Depot’s price target was raised to $450 by TD Cowen, but concerns remain over pricing power and flat housing activity.
20 January 2026
··
Coca-Cola stock price rises as tariff fears rattle markets — what KO investors watch next

Coca-Cola stock price rises as tariff fears rattle markets — what KO investors watch next

Coca-Cola shares rose 1.3% to $71.37 Tuesday afternoon, bucking a broader market selloff triggered by new U.S. tariff threats against Europe. CEO James Quincey said the company is “relatively immune to tariffs” ahead of its Feb. 10 earnings report. The S&P 500 and Nasdaq fell to one-month lows. EU leaders plan an emergency summit Thursday to discuss possible retaliatory tariffs.
20 January 2026
·
BitMine (BMNR) stock slides after $14.5 billion crypto hoard update, 50-billion-share approval

BitMine (BMNR) stock slides after $14.5 billion crypto hoard update, 50-billion-share approval

BitMine Immersion Technologies shares fell 8.3% to $28.57 Tuesday after disclosing $14.5 billion in crypto and cash holdings, including 4.2 million ether and 193 bitcoin. Shareholders approved raising authorized shares from 500 million to 50 billion, setting up potential dilution. The company bought 35,268 ether last week and plans to close a $200 million Beast Industries investment. Ether dropped 6.8% Tuesday, weighing on crypto stocks.
20 January 2026
··
Oklo Inc (OKLO) stock price slides as tariff shock hits Wall Street — what to watch next

Oklo Inc (OKLO) stock price slides as tariff shock hits Wall Street — what to watch next

Oklo Inc shares fell 5% to $90.18 Tuesday as U.S. stocks slid after President Trump warned of new tariffs on NATO allies. The drop followed recent Oklo announcements of a Meta-backed Ohio nuclear project and a Department of Energy pilot facility deal. Other nuclear stocks, including NuScale and Vistra, also declined. Investors are watching for funding updates and Oklo’s upcoming quarterly report.
20 January 2026
·
PepsiCo stock price steadies while Wall Street slides on tariff fears — what investors watch next

PepsiCo stock price steadies while Wall Street slides on tariff fears — what investors watch next

PepsiCo shares rose 0.4% to $146.94 Tuesday as the S&P 500 fell nearly 2% after President Trump’s tariff threats on Europe. The company drew attention for piloting “digital twins” of its factories with Nvidia and Siemens, aiming to boost throughput by up to 20%. PepsiCo also sold a California warehouse for $31.7 million. Its Q4 and full-year results are due Feb. 3.
20 January 2026
·
Capital One stock slides nearly 4% as credit-card rate cap deadline weighs on lenders

Capital One stock slides nearly 4% as credit-card rate cap deadline weighs on lenders

Capital One shares fell 3.7% to $230.18 Tuesday, trailing the S&P 500 banks index, as investors weighed a possible 10% cap on credit-card interest rates. The company is set to report fourth-quarter results Jan. 22. A federal judge gave preliminary approval to a $425 million class action settlement over its deposit business. Morgan Stanley raised its price target on Capital One to $300.
20 January 2026
··
Merck stock barely budges after five-year Moderna vaccine data keeps Keytruda trade in play

Merck stock barely budges after five-year Moderna vaccine data keeps Keytruda trade in play

Merck shares traded near $108.82 Tuesday after Merck and Moderna reported their personalized melanoma vaccine with Keytruda cut recurrence or death risk by 49% over five years in a phase 2b trial. The stock showed little change following the update. More data will be presented at a future medical meeting. Investors await Merck’s Feb. 3 earnings call for further details on its oncology portfolio.
20 January 2026
····
Why CrowdStrike stock is sliding today: CRWD hit by tariff jitters despite new cloud plan

Why CrowdStrike stock is sliding today: CRWD hit by tariff jitters despite new cloud plan

CrowdStrike shares fell 2.8% to $441.18 Tuesday as tech stocks slid following President Trump’s tariff threats against Europe. The company announced plans for new in-country clouds in Saudi Arabia, India, and the UAE. Investors shifted focus to upcoming U.S. inflation data and next week’s Federal Reserve meeting. Other cybersecurity stocks, including Zscaler and Palo Alto Networks, also declined.
20 January 2026
···
Intuitive Surgical stock slips as ISRG heads into key earnings call after softer 2026 outlook

Intuitive Surgical stock slips as ISRG heads into key earnings call after softer 2026 outlook

Intuitive Surgical shares fell 1.5% to $526.76 Tuesday afternoon, mirroring broader U.S. market declines. The company is set to report earnings Jan. 22 after signaling da Vinci procedure growth of 13%–15% in 2026 and preliminary Q4 revenue near $2.87 billion. Investors remain focused on procedure outlook and competition from Medtronic and Johnson & Johnson.
20 January 2026
··
Accenture stock (ACN) slides in tariff-hit selloff — what investors watch next

Accenture stock (ACN) slides in tariff-hit selloff — what investors watch next

Accenture shares fell 2.8% to $278.07 by early afternoon Tuesday, underperforming the broader U.S. market amid tariff threats tied to Greenland tensions and cautious tech spending outlooks. Morgan Stanley downgraded its view on North American IT hardware, citing weak budget growth. Accenture’s BOSLAN unit secured a role in the East Anglia TWO offshore wind project. Volatility rose across markets as investors reacted to geopolitical risks.
20 January 2026
·
1 … 285 286 287 288 289 … 732

Stock Market Today

  • KB Home Faces Earnings Decline Amid Challenging Housing Market Conditions
    April 6, 2026, 7:59 AM EDT. KB Home (KBH), a leading U.S. homebuilder operating in 49 markets, reported fiscal Q1 2026 revenue down 23% to $1.08 billion and a 14% drop in homes delivered. The adjusted gross profit margin fell to 15.5%, below the key 20% threshold, driven by price cuts and higher land costs. Analysts cut 2026 earnings estimates by 45.6% to $3.55 amid ongoing market pressures and geopolitical uncertainties. Despite solid community traffic and higher-margin orders, share prices have weakened over six months, reflecting persistent housing market struggles. KBH trades at a forward P/E of 14.3, indicating potential value but also risks as earnings decline continues.
Go toTop